JW (CAYMAN) THERAPEUTICS CO. LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.82 HKD | +7.06% |
|
+5.81% | -19.47% |
| Mar. 20 | JW (Cayman) Therapeutics Shrinks Loss in Fiscal 2023 | MT |
| Mar. 20 | JW Therapeutics Co. Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on JW (Cayman) Therapeutics Co. Ltd
Price target over the last 5 years
History of analyst recommendation changes
bde6964ba8dc89b56835ff17aace.ezPG5CLs6OSMU92z84R5o_IXLIVo_kfySFhakdI2ZDA.TVSwr1aOhNHEPorDhuwt65dWb7A8kRKcHGEf-OFVLmlMXJe-aNygyekY6Q~60da707b606f2e19b97ecaf13fdacaa1
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.683
CNY
Average target price
2.508
CNY
Spread / Average Target
+48.98%
High Price Target
3.285
CNY
Spread / Highest target
+95.13%
Low Price Target
2.025
CNY
Spread / Lowest Target
+20.29%
Consensus detail
Consensus revision (last 18 months)
Analysts covering JW (Cayman) Therapeutics Co. Ltd
| UBS |
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- 2126 Stock
- Consensus JW (Cayman) Therapeutics Co. Ltd
